4//SEC Filing
Groman Dan 4
Accession 0001104659-23-090487
CIK 0001868912other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:15 PM ET
Size
7.0 KB
Accession
0001104659-23-090487
Insider Transaction Report
Form 4
Enfusion, Inc.ENFN
Groman Dan
Chief Technology Officer
Transactions
- Award
Class A Common Stock
2023-08-09+4,855→ 116,638 total - Sale
Class A Common Stock
2023-08-10$8.08/sh−2,106$17,016→ 114,532 total
Footnotes (3)
- [F1]Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
- [F2]Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the Shares, and does not represent discretionary trades by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.91 to $8.36. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
Documents
Issuer
Enfusion, Inc.
CIK 0001868912
Entity typeother
Related Parties
1- filerCIK 0001881296
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:15 PM ET
- Size
- 7.0 KB